Valuation Merck KGaA

Stocks

Real-time Estimate Tradegate Other stock markets 16:27:29 09/06/2026 +04			5-day change	1st Jan Change
137.95 ^EUR	+0.36%		+5.39%	+12.40%

10:51am	Merck Announces Management Appointments	CI
06-01	MERCK KGAA : Receives a Buy rating from JP Morgan	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	98,695	78,651	62,651	60,825	53,304	59,760	-	-
Change	-	-20.31%	-20.34%	-2.91%	-12.37%	12.11%	-	-
Enterprise Value (EV) ¹	107,596	86,979	70,610	68,609	62,533	67,289	65,385	63,502
Change	-	-19.16%	-18.82%	-2.83%	-8.86%	7.61%	-2.83%	-2.88%
P/E ratio	32.3x	23.6x	22.2x	21.9x	20.4x	23.2x	20.2x	18x
PBR	4.63x	3.03x	2.35x	2.03x	1.86x	1.95x	1.83x	1.7x
PEG	-	2.68x	-1.5x	-14.21x	-3.34x	-17.37x	1.3x	1.5x
Capitalization / Revenue	5.01x	3.54x	2.98x	2.88x	2.53x	2.84x	2.71x	2.57x
EV / Revenue	5.47x	3.91x	3.36x	3.24x	2.96x	3.2x	2.96x	2.73x
EV / EBITDA	17.6x	12.7x	12x	11.3x	10.2x	11.4x	10.3x	9.31x
EV / EBIT	25.7x	19.4x	19.6x	18.8x	17.4x	18.6x	16.4x	14.3x
EV / FCF	30.3x	31.9x	36.9x	23.8x	26.6x	24x	21.7x	19.4x
FCF Yield	3.3%	3.14%	2.71%	4.2%	3.75%	4.17%	4.6%	5.15%
Dividend per Share ²	1.85	2.2	2.2	2.2	2.2	2.328	2.416	2.515
Rate of return	0.81%	1.22%	1.53%	1.57%	1.79%	1.69%	1.76%	1.83%
EPS ²	7.03	7.65	6.49	6.39	6	5.92	6.821	7.654
Distribution rate	26.3%	28.8%	33.9%	34.4%	36.7%	39.3%	35.4%	32.9%
Net sales ¹	19,687	22,232	20,993	21,156	21,102	21,041	22,057	23,284
EBITDA ¹	6,103	6,849	5,879	6,072	6,109	5,922	6,331	6,824
EBIT ¹	4,179	4,474	3,609	3,645	3,601	3,609	3,990	4,428
Net income ¹	3,055	3,326	2,824	2,777	2,608	2,554	2,929	3,271
Net Debt ¹	8,902	8,328	7,959	7,784	9,229	7,529	5,624	3,741
Reference price ²	227.00	180.90	144.10	139.90	122.60	137.45	137.45	137.45
Nbr of stocks (in thousands)	434,778	434,778	434,778	434,778	434,778	434,778	-	-
Announcement Date	03/03/22	02/03/23	07/03/24	06/03/25	05/03/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MERCK KGAA	23.22x	3.2x	11.36x	1.69%	69.01B
MERCK & CO., INC.	53.32x	4.96x	20.16x	2.8%	295B
HALOZYME THERAPEUTICS, INC.	10.51x	5.41x	8.33x	-	8.39B
KYOWA KIRIN CO., LTD.	15.24x	1.91x	6.55x	2.87%	7.72B
SK BIOPHARMACEUTICALS CO., LTD.	21.23x	6.17x	16.97x	-.--%	4.15B
YUHAN CORPORATION	40.2x	2.27x	27.72x	0.76%	3.47B
BETTA PHARMACEUTICALS CO., LTD.	26.16x	5.03x	14.39x	-	3.04B
SUPERNUS PHARMACEUTICALS, INC.	102.65x	-	-	-.--%	2.58B
Average	36.57x	4.14x	15.07x	1.35%	49.19B
Weighted average by Cap.	46.04x	4.59x	18.07x	2.53%